Enlivex Therapeutics Ltd. (ENLV) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Cash from Operations | -2.9M | -2.3M | -1.23M | -4.62M | -4.08M | -2.62M | -1.8M | -4.51M | -5.03M | -5.44M | -7.02M | -5.78M | -4.82M | -6.59M | -9.27M | -3.27M | -6.59M | -4.2M | -4.41M | -2.34M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 28.95% | 12.29% | 31.77% | -2.53% | 18.76% | 51.88% | 74.41% | 22.03% | -4.33% | 17.5% | 24.26% | -76.93% | 26.9% | -56.94% | -110.27% | -39.7% | -14.45% | -78.54% | -20.03% | -400.39% |
| Net Income | 1.24B | -2.21M | -1.87M | -3.45M | -5.18M | -2.6M | -3.1M | -4.14M | -9.1M | -5.96M | -6.79M | -7.22M | -7.19M | -5.73M | -9.91M | -8.22M | -4.74M | -3.42M | -3.11M | -3.2M |
| Depreciation & Amortization | 76K | 81K | 85K | 90K | 36K | 161K | 160K | 188K | 200K | 214K | 212K | 209K | 221K | 192K | 176K | 188K | 150K | 157K | 122K | 117K |
| Stock-Based Compensation | 915K | 280K | 295K | 293K | 917K | 377K | 388K | 383K | 400K | 407K | 511K | 633K | 757K | 470K | 697K | 788K | 1.7M | 377K | 652K | 190K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -112.87K | 102K | 234K | 1.39M | 0 | 0 | 2.92M | 1.97M | -3.38M | -629K | -1.2M | -388K |
| Other Non-Cash Items | -1.25B | 24.72K | 89.93K | -1.08M | 392.21K | 944K | 181K | 608K | 2.99M | 216K | 226K | 208K | 202K | -2.69M | 226K | 185K | -3.16M | -542K | -1.14M | -336K |
| Working Capital Changes | 1.36M | -196.2K | 172K | -470K | 663.79K | -1.5M | 570K | -962K | 993.35K | -415K | -1.41M | -1.01M | 1.19M | 1.16M | -3.38M | 1.83M | -541K | -769K | -936K | 889K |
| Change in Receivables | -3.6M | 214.33K | 36.64K | 117K | 640 | -1.35M | 1.42M | 355K | 251.57K | 501.38K | -658.28K | 492K | -471.19K | 939.23K | -1.26M | 1.06M | -664.06K | -419.67K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -501.38K | 658.28K | -492K | 471.19K | -939.23K | 1.26M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.63M | -185.6K | 9K | -278K | 716.15K | -211K | -341K | -183K | 35.95K | -914K | 217K | -457K | 989K | 390K | -691K | 480K | -154K | 495K | 202K | -101K |
| Cash from Investing | -9.83M | 4.16M | 1.09M | 3.17M | 3.36M | 1.4M | -794K | 5.1M | 4.1M | 3.94M | -2.7M | -31.35M | -2.88M | 44.04M | -38.32M | 59.67M | -5.35M | 14.32M | 12.2M | -59.59M |
| Capital Expenditures | -20.69M | -23.55K | -7K | -32K | -35.25K | -9K | -16K | -43K | -5.94K | -29K | -38K | -162K | -2.58M | -1.19M | -3.4M | -952K | -1.03M | -120K | -299K | -173K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 514.13K | 361.42K | 0 | 0 | 303.51K | 0 | 0 | 224K | 48.92K | -1.27K | 80.68K | 0 | -10.66K | -45.23K | 1.45M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 323K | 264.45K | 336K | -21.19K | 1.77M | 34.91K | 53K | 4.14K | 5.72K | 1.32K | -31.18K | -295 | 45.23K | -34.92K | 60.63K | -4.31K | 14.45K | 12.5K | -59.42K |
| Cash from Financing | 10.44M | 376.11K | 950 | 197K | 1.26M | 250K | 4.42M | 524K | -1.28K | -5.56K | 42K | 318K | -1.02K | 50K | 50K | 50K | -3K | 67K | 2K | 60.92M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 10.44M | 376.11K | 950 | 197K | 1.26M | 250K | 4.38M | 524K | -1.28K | -5.56K | 42K | 318K | -1.06K | 47.7K | 47.74K | 50K | -3K | 363.2K | 104.51K | 53.17M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 2K | 0 | 40.51K | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 50K | 50K | 0 | 67K | 2K | 7.74M |
| Net Change in Cash | -2.19M | 2.19M | -161K | -1.25M | 535K | -970K | 1.83M | 1.1M | -1.16M | -1.49M | -9.68M | -36.81M | -7.69M | 37.5M | -47.54M | 56.45M | -11.69M | 9.74M | 8.18M | -1.61M |
| Free Cash Flow | -2.91M | -2.32M | -1.21M | -4.66M | -4.15M | -2.63M | -1.81M | -4.55M | -5.03M | -5.47M | -7.06M | -5.95M | -7.4M | -7.78M | -12.67M | -4.22M | -7.62M | -4.32M | -4.71M | -2.51M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 29.89% | 11.69% | 33.54% | -2.26% | 17.49% | 51.98% | 74.32% | 23.43% | 31.98% | 29.74% | 44.28% | -40.87% | 2.95% | -80.12% | -169.1% | -67.97% | -22.18% | -58.57% | -23.89% | -439.59% |
| FCF per Share | -0.06 | -0.10 | -0.05 | -0.21 | -0.19 | -0.12 | -0.09 | -0.24 | -0.27 | -0.29 | -0.38 | -0.32 | -0.40 | -0.42 | -0.69 | -0.23 | -0.42 | -0.24 | -0.26 | -0.15 |
| FCF Conversion (FCF/Net Income) | -0.00x | 1.04x | 0.66x | 1.34x | 0.79x | 1.01x | 0.58x | 1.09x | 0.55x | 0.91x | 1.03x | 0.80x | 0.67x | 1.15x | 0.94x | 0.40x | 1.39x | 1.23x | 1.42x | 0.73x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |